Sulperazon  1 g/1 g powder for solution for injection България - български - Изпълнителна агенция по лекарствата

sulperazon  1 g/1 g powder for solution for injection

pfizer europe ma eeig - Цефоперазон, Сульбактам - 1 g/1 g powder for solution for injection

Zavicefta Европейски съюз - български - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - Антибактериални средства за подаване на заявления, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Трябва да се вземат предвид официалните препоръки за правилното използване на антибактериални агенти.

GAMARED LC intramammary suspension България - български - БАБХ (Българска агенция по безопасност на храните)

gamared lc intramammary suspension

"Лекоом" АД - procaine benzylpenicillin monohydrate, neomycin sulfate, dihydrostreptomycin sulfate, novobiocin sodium, prednisolone - интрамамрна суспензия - 100 mg/10 ml; 102 000 iu/10 ml; 125 mg/10 ml; 100 mg/10 ml; 10 mg/10 ml - говеда

Piperacillin/Tazobactam Kabi  2 g/0,25 g powder for solution for infusion България - български - Изпълнителна агенция по лекарствата

piperacillin/tazobactam kabi  2 g/0,25 g powder for solution for infusion

Фрезениус Каби България ЕООД - Пиперациллин, Тазобактам - 2 g/0,25 g powder for solution for infusion

Pedmarqsi Европейски съюз - български - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Всички други терапевтични продукти - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.